Medications

Prices for new brand-name prescription drugs spike

A new study out of Brigham and Women's Hospital shows how newly marketed brand-name drugs in the U.S. are driving up health care spending, resulting in "detrimental effects for patient access and affordability."

Vaccination

FDA advisers weigh COVID-19 booster shots for fall

Outlining a daunting timeline for development of any updated COVID-19 vaccine for next fall, federal health officials told an expert advisory panel on Wednesday that clinical trials of potential candidates would have to begin ...

page 7 from 40